WHO ICTRP trial
A single-center, randomized, double-blind, placebo-controlled, dose escalation…
ChiCTR1900028589 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900028589 |
|---|---|
| Public title | A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects. |
| Scientific title | A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects. |
| Primary sponsor | The First Affiliated Hospital, Zhejiang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | diabetes |
| Interventions | Group 1:100mg catalpol tablets;Group 2:200mg catalpol tablets;Group 3:400mg catalpol tablets;Group 4:800mg catalpol tablets;Group 5:1200mg catalpol tablets;Group 6:1500mg catalpol tablets |
| Registration date | Dec 28, 2019 |
| Target size | Group 1:4;Group 2:4;Group 3:8;Group 4:8;Group 5:8;Group 6:4 |
| Secondary IDs | ChiMCTR1900002878 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: